Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,255,646
+$14,829,239 QoQ
Shares Held
155,378
+1143.3% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#58
of 274 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Derivatives in CELC
reported options exposure · as of Jun 30, 2026CallValue
$42,120,012
CallShares
402,600
PutValue
$31,166,298
PutShares
297,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,919,181 across 348 Biotechnology names. CELC ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in CELC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,255,646 | 155,378 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $31,166,298 | 297,900 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $42,120,012 | 402,600 | Call | Other | 2026-08-14 | |
| 2026-03-31 | $1,426,407 | 12,497 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $12,749,438 | 111,700 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $65,116,870 | 570,500 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $30,650,102 | 307,300 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $9,165,607 | 91,895 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $10,223,350 | 102,500 | Put | Other | 2026-02-17 | |
| 2025-09-30 | $5,285,800 | 107,000 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $9,168,640 | 185,600 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $536,670 | 40,200 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $287,025 | 21,500 | Put | Other | 2025-08-14 | |
| 2025-06-30 | $795,993 | 59,625 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $404,713 | 40,031 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $212,058 | 16,200 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $279,026 | 21,316 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $371,259 | 24,900 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $237,788 | 14,517 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $200,880 | 9,300 | Call | Defined | 2024-05-07 | |
| 2023-06-30 | $141,674 | 12,903 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $103,525 | 10,100 | Put | Defined | 2023-05-16 | |
| 2023-03-31 | $929,910 | 90,723 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $184,651 | 13,180 | Shares | Defined | 2023-02-14 | |
| 2020-03-31 | $71,721 | 11,034 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||